CCL5 Antikörper (AA 24-91)
-
- Target Alle CCL5 Antikörper anzeigen
- CCL5 (Chemokine (C-C Motif) Ligand 5 (CCL5))
-
Bindungsspezifität
- AA 24-91
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser CCL5 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA
- Kreuzreaktivität
- Human
- Aufreinigung
- >95%, Protein G purified
- Immunogen
- Recombinant Human C-C motif chemokine 5 protein (24-91AA)
- Isotyp
- IgG
- Top Product
- Discover our top product CCL5 Primärantikörper
-
-
- Applikationshinweise
- Recommended dilution: WB:1:1000-1:5000,
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 - Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- CCL5 (Chemokine (C-C Motif) Ligand 5 (CCL5))
- Andere Bezeichnung
- CCL5 (CCL5 Produkte)
- Synonyme
- Rantes antikoerper, Scya5 antikoerper, D17S136E antikoerper, RANTES antikoerper, SCYA5 antikoerper, SIS-delta antikoerper, SISd antikoerper, TCP228 antikoerper, eoCP antikoerper, MuRantes antikoerper, C-C motif chemokine 5-like antikoerper, C-C motif chemokine ligand 5 antikoerper, chemokine (C-C motif) ligand 5 antikoerper, LOC100230935 antikoerper, CCL5 antikoerper, Ccl5 antikoerper
- Hintergrund
-
Background: Chemoattractant for blood monocytes, memory T-helper cells and eosinophils. Causes the release of histamine from basophils and activates eosinophils. Binds to CCR1, CCR3, CCR4 and CCR5. One of the major HIV-suppressive factors produced by CD8+ T-cells. Recombinant RANTES protein induces a dose-dependent inhibition of different strains of HIV-1, HIV-2, and simian immunodeficiency virus (SIV). The processed form RANTES(3-68) acts as a natural chemotaxis inhibitor and is a more potent inhibitor of HIV-1-infection. The second processed form RANTES(4-68) exhibits reduced chemotactic and HIV-suppressive activity compared with RANTES(1-68) and RANTES(3-68) and is generated by an unidentified enzyme associated with monocytes and neutrophils.
Aliases: Beta chemokine RANTES antibody, Beta chemokine RANTES precursor antibody, C C motif chemokine 5 antibody, CCL 5 antibody, CCL5 antibody, CCL5_HUMAN antibody, Chemokine (C C motif) ligand 5 antibody, Chemokine CC Motif Ligand 5 antibody, D17S136E antibody, EoCP antibody, Eosinophil chemotactic cytokine antibody, MGC17164 antibody, RANTES(4-68) antibody, Regulated upon activation normally T expressed and presumably secreted antibody, SCYA 5 antibody, SCYA5 antibody, SIS delta antibody, SIS-delta antibody, SISd antibody, Small inducible cytokine A5 (RANTES) antibody, Small inducible cytokine A5 antibody, Small inducible cytokine subfamily A (Cys Cys) member 5 antibody, Small-inducible cytokine A5 antibody, T cell specific protein p288 antibody, T cell specific protein RANTES antibody, T cell specific RANTES protein antibody, T cell-specific protein P228 antibody, T-cell-specific protein RANTES antibody, TCP 228 antibody, TCP228 antibody
- UniProt
- P13501
- Pathways
- Cellular Response to Molecule of Bacterial Origin, Regulation of G-Protein Coupled Receptor Protein Signaling, Smooth Muscle Cell Migration
-